Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

bmiMD vs Wellorithm

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

bmiMD

Best for mainstream telehealth GLP-1 access
★★★3.6
SemaglutideTirzepatide
Visit bmiMD
7.2

Wellorithm

Best for compounded GLP-1 access with oral tablet options across 49 states
★★★3.6
Compounded SemaglutideCompounded TirzepatideOral Dissolving TabletsInjectable
Visit Wellorithm

Side-by-Side Comparison

FeaturebmiMDWellorithm
Overall Score7.1/107.2/10
Starting Price
Editorial Rating3.6 ★ /53.6 ★ /5
Features2 features4 features
States Available5049
Compounded
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

bmiMD

Pros

  • Both semaglutide and tirzepatide available

Cons

  • Pricing not publicly disclosed

Wellorithm

Pros

  • Four compounded GLP-1 formats: semaglutide injectable, semaglutide oral dissolving tablets, tirzepatide injectable, tirzepatide oral dissolving tablets
  • Available in 49 states — broader coverage than most compounded GLP-1 telehealth providers
  • Board-certified obesity specialists with virtual consultations
  • 2-minute quiz onboarding — fast async approval path
  • 24/7 support with dedicated phone line
  • Katalys RevOffers tracking pixel detected — affiliate program active

Cons

  • Not available in Louisiana
  • Pricing not publicly disclosed on their website — requires completing the intake quiz
  • No visible LegitScript certification or PCAB accreditation
  • Compounded medications have not been reviewed or approved by the FDA (stated on their site)

Our Verdict

Winner: WellorithmScore: 7.2/10

Wellorithm edges out bmiMD with a higher overall score of 7.2/10 and is particularly strong for compounded GLP-1 access with oral tablet options across 49 states. bmiMD remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.